Suppr超能文献

针对高危个体和整个人群的糖尿病预防干预措施的成本效益:系统评价。

Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.

机构信息

Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.

College of Nursing and Disability, Aging and Technology Cluster, University of Central Florida, Orlando, FL.

出版信息

Diabetes Care. 2020 Jul;43(7):1593-1616. doi: 10.2337/dci20-0018.

Abstract

OBJECTIVE

We conducted a systematic review of studies evaluating the cost-effectiveness (CE) of interventions to prevent type 2 diabetes (T2D) among high-risk individuals and whole populations.

RESEARCH DESIGN AND METHODS

Interventions targeting high-risk individuals are those that identify people at high risk of developing T2D and then treat them with either lifestyle or metformin interventions. Population-based prevention strategies are those that focus on the whole population regardless of the level of risk, creating public health impact through policy implementation, campaigns, and other environmental strategies. We systematically searched seven electronic databases for studies published in English between 2008 and 2017. We grouped lifestyle interventions targeting high-risk individuals by delivery method and personnel type. We used the median incremental cost-effectiveness ratio (ICER), measured in cost per quality-adjusted life year (QALY) or cost saved to measure the CE of interventions. We used the $50,000/QALY threshold to determine whether an intervention was cost-effective or not. ICERs are reported in 2017 U.S. dollars.

RESULTS

Our review included 39 studies: 28 on interventions targeting high-risk individuals and 11 targeting whole populations. Both lifestyle and metformin interventions in high-risk individuals were cost-effective from a health care system or a societal perspective, with median ICERs of $12,510/QALY and $17,089/QALY, respectively, compared with no intervention. Among lifestyle interventions, those that followed a Diabetes Prevention Program (DPP) curriculum had a median ICER of $6,212/QALY, while those that did not follow a DPP curriculum had a median ICER of $13,228/QALY. Compared with lifestyle interventions delivered one-on-one or by a health professional, those offered in a group setting or provided by a combination of health professionals and lay health workers had lower ICERs. Among population-based interventions, taxing sugar-sweetened beverages was cost-saving from both the health care system and governmental perspectives. Evaluations of other population-based interventions-including fruit and vegetable subsidies, community-based education programs, and modifications to the built environment-showed inconsistent results.

CONCLUSIONS

Most of the T2D prevention interventions included in our review were found to be either cost-effective or cost-saving. Our findings may help decision makers set priorities and allocate resources for T2D prevention in real-world settings.

摘要

目的

我们对评估干预措施预防 2 型糖尿病(T2D)的成本效益(CE)的研究进行了系统回顾,这些干预措施针对的是高危人群和整个人群。

研究设计和方法

针对高危人群的干预措施是指那些确定有发展为 T2D 高风险的人,然后用生活方式或二甲双胍干预治疗他们的措施。基于人群的预防策略是指那些针对整个人群的策略,而不考虑风险水平,通过政策实施、宣传活动和其他环境策略来产生公共卫生影响。我们系统地在七个英文电子数据库中搜索了 2008 年至 2017 年发表的研究。我们根据提供方法和人员类型对针对高危人群的生活方式干预措施进行了分组。我们使用增量成本效益比(ICER)的中位数来衡量干预措施的 CE,用质量调整生命年(QALY)或节省的成本/每质量调整生命年(QALY)来衡量。我们使用 50000 美元/QALY 的阈值来确定干预措施是否具有成本效益。ICER 以 2017 年的美元表示。

结果

我们的综述包括 39 项研究:28 项针对高危人群的干预措施和 11 项针对整个人群的干预措施。从医疗保健系统或社会角度来看,高危人群中的生活方式和二甲双胍干预措施都是具有成本效益的,与不干预相比,其 ICER 的中位数分别为 12510 美元/QALY 和 17089 美元/QALY。在生活方式干预措施中,遵循糖尿病预防计划(DPP)课程的干预措施的 ICER 中位数为 6212 美元/QALY,而不遵循 DPP 课程的干预措施的 ICER 中位数为 13228 美元/QALY。与一对一或由卫生专业人员提供的生活方式干预措施相比,在小组环境中提供或由卫生专业人员和非专业卫生工作者联合提供的生活方式干预措施的 ICER 较低。在基于人群的干预措施中,从医疗保健系统和政府的角度来看,对含糖饮料征税都是具有成本效益的。对其他基于人群的干预措施的评估,包括水果和蔬菜补贴、社区教育计划以及对建筑环境的修改,显示出不一致的结果。

结论

我们综述中包括的大多数 2 型糖尿病预防干预措施都被认为是具有成本效益的或具有成本节约性的。我们的研究结果可能有助于决策者在实际环境中为 2 型糖尿病的预防设定优先级和分配资源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验